Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px

Product › Details

Mayzent

	Next higher product group	siponimod (BAF312)
	Status	2019-03-27 registration start
	Organisation	Novartis AG (NYSE: NVS)
	Group	Novartis (Group)
	Source	Novartis AG. (4/24/19). "Press Release: Novartis Starts 2019 with Strong Sales and Double Digit Core Operating Income Growth, Mayzent Launch and Alcon Spin-off, Profit Guidance Upgraded". Basel.

Record changed: 2023-07-10

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for pharmaceutical

[1] Citryll B.V.. (12/9/24). "Press Release: Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders". Oss....
[2] Formycon AG. (12/9/24). "Press Release: MS Pharma Becomes Partner for the Commercialization of FYB202 / Ustekinumab in the MENA Region". Planegg-Martinsried....
[3] Eckert & Ziegler SE. (12/5/24). "Press Release: Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments". Berlin....
[4] Leon-Nanodrugs GmbH. (12/5/24). "Press Release: Feasibility Study with Evonik Confirms Leon’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery". Munich, Planegg....
[5] Antag Therapeutics. (12/4/24). "Press Release: Antag Therapeutics Announces €80 Million Series A Financing". Copenhagen....
[6] Nouscom S.r.l.. (12/3/24). "Press Release: Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chief Business Officer". Basel....
[7] Eckert & Ziegler SE. (12/3/24). "Press Release: Eckert & Ziegler – Changes in the Executive Board and Supervisory Board". Berlin....
[8] Tubulis GmbH. (12/3/24). "Press Release: Gilead and Tubulis Enter into Exclusive Option and Licence Agreement to Develop ADC Candidate for Select Solid Tumor Target". Foster City, CA & Munich....
[9] PTC Therapeutics, Inc.. (12/2/24). "Press Release: PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program". Warren, NJ....
[10] Medigene AG. (11/26/24). "Press Release: Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top